Events

Search Loading
Australian Life Science Investment Showc...
Date: 23rd May 2012 Location: Ernst & Young Headquarters, CITIC Tower, 1 Tim Mei Avenue, Central, Hong Kong
<acronym title='2012 Annual Stockbrokers Conference' style='cursor: hand'>2012 Annual Stockbrokers Conference</acronym>
2012 Annual Stockbrokers Conference
Date: Thursday, 31 May and Friday, 1 June 2012 Location: Crown Promenade, Melbourne, Level 1, 8 Whiteman St, Southbank
CeBIT Australia is Australasia’s numbe...
Date: 22 – 24 May 2012 Location: Darling Harbour, Sydney
Private Wealth Forum
Date: Perth May 23, Sydney May 28, Melbourne May 29
Wholesale Investor Perth Small Cap Showc...
Date: June 12th, 2012 Location: PwC Offices Perth, QV1 Building Lv 19-21, 250 St Georges Tce, Perth
Eco Innovation Forum 2012
Date: 23 May 2012 Location: NSW Trade & Investment Centre, Level 47 MLC Centre, 19 Martin Place, Sydney
 

Australian Life Science Investment Showcase: Hong Kong 2012

Date: 23rd May 2012

Location: Ernst & Young Headquarters, CITIC Tower, 1 Tim Mei Avenue, Central, Hong Kong


Participating companies

Allied Healthcare Group (ASX:AHZ) www.alliedhealthcaregroup.com.au
Global Kinetics Corporation
Kahne Limited www.kahneanimalhealth.com
Living Cell Technologies (ASX:LCT) www.lctglobal.com
Mesynthes www.mesynthes.com
Prana Biotechnology (ASX:PBT) www.pranabio.com
Register Now

Attendance is complimentary but limited, so please REGISTER ONLINE – CLICK HERE or contact AusBiotech’s Investment Program Manager, Hayley Laing hlaing@ausbiotech.org by Monday 21 May 2012

AusBiotech investment mission to Hong Kong

Hong Kong is a major financial centre in Asia, a portal for investment funds and showcase/hub in the region and the springboard to mainland China for two way investments and collaborations. Hong Kong’s biotech industry is service-based, and has got strong local government support for JV and international partnership.

AusBiotech is venturing to Hong Kong and will host the ‘Australian Life Science Showcase: Hong Kong 2012’ in conjunction with the ASX’s small to mid-cap event. Expanding on our global relationship with Ernst & Young, the Showcase will be held at their corporate headquarters in Hong Kong.

The Australian business mission, with the assistance from Austrade, will also include the signing of an official memorandum of understanding (MOU) between the Australian and Hong Kong biotechnology industries and associations. An event heralding the MOU signing is planned for Thursday 24 May at the Hong Kong Science Park and will include one-on-one business matching and networking opportunities for participating companies.

AusBiotech will attract a high-quality audience from the Hong Kong and Chinese investment community, including angel investors, venture capitalists, fund managers and investment bankers, working closely with Austrade and the Hong Kong Biotechnology Organization to develop connection through the Hong Kong Business Angel Network (HKBAN) and the Hong Kong Venture Capital Association (HKVCA).
Participation / further information